X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALKEM LABORATORIES - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALKEM LABORATORIES BIOCON /
ALKEM LABORATORIES
 
P/E (TTM) x 18.7 - - View Chart
P/BV x 2.9 6.1 48.7% View Chart
Dividend Yield % 0.4 0.7 54.9%  

Financials

 BIOCON    ALKEM LABORATORIES
EQUITY SHARE DATA
    BIOCON
Mar-18
ALKEM LABORATORIES
Mar-16
BIOCON /
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,1881,589 74.8%   
Low Rs3051,232 24.8%   
Sales per share (Unadj.) Rs68.7417.5 16.5%  
Earnings per share (Unadj.) Rs7.656.3 13.4%  
Cash flow per share (Unadj.) Rs14.064.7 21.6%  
Dividends per share (Unadj.) Rs1.0012.70 7.9%  
Dividend yield (eoy) %0.10.9 14.9%  
Book value per share (Unadj.) Rs86.3292.9 29.5%  
Shares outstanding (eoy) m600.00119.57 501.8%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.93.4 321.5%   
Avg P/E ratio x98.925.1 394.5%  
P/CF ratio (eoy) x53.421.8 245.1%  
Price / Book Value ratio x8.64.8 179.6%  
Dividend payout %13.222.6 58.7%   
Avg Mkt Cap Rs m447,900168,653 265.6%   
No. of employees `0006.1NA-   
Total wages/salary Rs m9,3119,171 101.5%   
Avg. sales/employee Rs Th6,705.8NM-  
Avg. wages/employee Rs Th1,514.2NM-  
Avg. net profit/employee Rs Th736.9NM-  
INCOME DATA
Net Sales Rs m41,23449,915 82.6%  
Other income Rs m2,0621,645 125.3%   
Total revenues Rs m43,29651,561 84.0%   
Gross profit Rs m8,2918,482 97.7%  
Depreciation Rs m3,8511,006 382.9%   
Interest Rs m615671 91.7%   
Profit before tax Rs m5,8878,451 69.7%   
Minority Interest Rs m213-114 -187.2%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5691,606 97.7%   
Profit after tax Rs m4,5316,731 67.3%  
Gross profit margin %20.117.0 118.3%  
Effective tax rate %26.719.0 140.2%   
Net profit margin %11.013.5 81.5%  
BALANCE SHEET DATA
Current assets Rs m41,48627,062 153.3%   
Current liabilities Rs m21,41315,324 139.7%   
Net working cap to sales %48.723.5 207.0%  
Current ratio x1.91.8 109.7%  
Inventory Days Days6467 96.2%  
Debtors Days Days9441 228.1%  
Net fixed assets Rs m50,66112,610 401.8%   
Share capital Rs m3,000239 1,254.7%   
"Free" reserves Rs m48,80834,490 141.5%   
Net worth Rs m51,80835,027 147.9%   
Long term debt Rs m17,8981,212 1,477.2%   
Total assets Rs m99,89754,387 183.7%  
Interest coverage x10.613.6 77.7%   
Debt to equity ratio x0.30 998.7%  
Sales to assets ratio x0.40.9 45.0%   
Return on assets %5.213.6 37.9%  
Return on equity %8.719.2 45.5%  
Return on capital %9.624.9 38.8%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m12,0586,563 183.7%   
Fx outflow Rs m7,3483,012 244.0%   
Net fx Rs m4,7103,552 132.6%   
CASH FLOW
From Operations Rs m6,6217,259 91.2%  
From Investments Rs m-6,8401,864 -366.9%  
From Financial Activity Rs m-2,397-9,273 25.9%  
Net Cashflow Rs m-2,612-150 1,741.3%  

Share Holding

Indian Promoters % 40.4 66.9 60.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 33.1 25.4%  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 0.0 -  
Shareholders   109,995 68,381 160.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  CADILA HEALTHCARE  SUVEN LIFESCIENCES  

Compare BIOCON With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades above 39,000-Mark; Tata Motors Gains Over 4%(12:30 pm)

Share markets in India are presently trading on a positive note. Barring IT sector, all sectoral indices are trading in green with stocks in the oil & gas sector.

Related Views on News

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (4QFY18); Net Profit Up 19.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 19.8% YoY). Sales on the other hand came in at Rs 12 bn (up 25.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jul 16, 2019 12:23 PM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS